The study provides evidence that altered expression of genes regulated posttranscriptionally by CUG-BP, such as cTNT, may contribute to myotonic dystrophy pathogenesis.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications in myotonic dystrophy; hypothesis-generating from animal data and leaves open human validation.
Myotonic dystrophy (DM) is caused by a CTG expansion in the 3' untranslated region of the DM gene. One model of DM pathogenesis suggests that RNAs from the expanded allele create a gain-of-function mutation by the inappropriate binding of proteins to the CUG repeats. Data presented here indicate that the conserved heterogeneous nuclear ribonucleoprotein, CUG-binding protein (CUG-BP), may mediate the trans-dominant effect of the RNA. CUG-BP was found to bind to the human cardiac troponin T (cTNT) pre-messenger RNA and regulate its alternative splicing. Splicing of cTNT was disrupted in DM striated muscle and in normal cells expressing transcripts that contain CUG repeats. Altered expression of genes regulated posttranscriptionally by CUG-BP therefore may contribute to DM pathogenesis.
No takes yet. Share an insight, caveat, or question.
Philips et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: